Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Microbot Medical Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Microbot Medical Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Microbot Medical Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was $6,758,000, a 1182% increase year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Microbot Medical Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,758,000 +$6,231,000 +1182% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $4,135,000 +$1,622,000 +65% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 $527,000 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $2,513,000 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q2 2019 $9,129,000 +$1,082,000 +13% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $9,606,000 +$119,000 +1.3% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $5,263,000 -$5,551,000 -51% 31 Dec 2018 10-Q 14 Aug 2019 2019 Q2
Q3 2018 $6,700,000 -$5,056,000 -43% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $8,047,000 -$5,031,000 -38% 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $9,487,000 +$4,485,000 +90% 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q4 2017 $10,814,000 +$8,105,000 +299% 31 Dec 2017 10-Q 14 Aug 2019 2019 Q2
Q3 2017 $11,756,000 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $13,078,000 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $5,002,000 31 Mar 2017 10-Q 14 Aug 2018 2018 Q2
Q4 2016 $2,709,000 31 Dec 2016 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.